Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x100px
Document › Details

CRISPR Therapeutics AG. (11/5/24). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results". Zug & Boston, MA.

Organisations Organisation CRISPR Therapeutics AG (Nasdaq: CRSP)
  Group CRISPR Therapeutics (Group)
  Organisation 2 Vertex Pharmaceuticals Inc. (Nasdaq: VRTX)
  Group Vertex Pharmaceuticals (Group)
Products Product CRISPR-Cas9 technology
  Product 2 Casgevy™
Persons Person Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)
  Person 2 Eides, Rachel (CRISPR Therapeutics 202212 Media Relations)
     


   
Record changed: 2024-12-09

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x200px

More documents for CRISPR Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2025 SBD25 Basel 650x300px




» top